Menu

Skip to content
  • Home
  • About Us
  • Contact Us
  • Publications
  • Research
  • Team

Brody Laboratory 

icahn.mssm.edu   /   Inside Mount Sinai Blog

Menu

Skip to content
  • Home
  • About Us
  • Contact Us
  • Publications
  • Research
  • Team

CAR T-cells for hematologic malignancies

Posted on May 25, 2016 by brodyj
re-directing immune cells to become anti-cancer cells

Re-directing immune cells to become anti-cancer cells.

 

This entry was posted in Adoptive T cell transfer therapy and tagged CAR-T, clinical trials, immunotherapy, leukemia, lymphoma. Bookmark the permalink.

Post navigation

← A Teaching Hospital
Sanjay Gupta MD interview →

in situ vaccination for lymphoma

  • Fox 5 WNYW interview
  • Sanjay Gupta MD interview
  • CAR T-cells for hematologic malignancies
  • A Teaching Hospital

Archives

  • June 2016
  • May 2016

Categories

  • Adoptive T cell transfer therapy
  • cancer immunotherapy
  • in situ vaccine

Tags

cancer immunotherapy CAR-T clinical trials Flt3L immunotherapy in situ in situ vaccine leukemia lymphoma patients radiotherapy remission targeted therapy TLRa vaccine

Careers | Contact Us | Privacy | Legal
800-MD-SINAI
© Icahn School of Medicine at Mount Sinai